Your browser doesn't support javascript.
loading
Neonatal death: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
Pathirana, Jayani; Muñoz, Flor M; Abbing-Karahagopian, Victoria; Bhat, Niranjan; Harris, Tara; Kapoor, Ambujam; Keene, Daniel L; Mangili, Alexandra; Padula, Michael A; Pande, Stephen L; Pool, Vitali; Pourmalek, Farshad; Varricchio, Frederick; Kochhar, Sonali; Cutland, Clare L.
Afiliação
  • Pathirana J; Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, Johannesburg, South Africa; Department of Science and Technology, National Research Foundation, Vaccine Preventable Diseases, South Africa; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Af
  • Muñoz FM; Departments of Pediatrics, Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.
  • Abbing-Karahagopian V; Global Clinical Research & Development - Epidemiology Novartis/GSK Vaccines, Amsterdam, The Netherlands.
  • Bhat N; Program for Appropriate Technology in Health (PATH), Seattle, USA.
  • Harris T; Immunization and Vaccine Preventable Diseases, Public Health Ontario, Canada.
  • Kapoor A; Immunization Technical Support Unit - Ministry of Health and Family Welfare, Public Health Foundation of India, New Delhi, India.
  • Keene DL; Department of Pediatrics, Faculty of Medicine, University of Ottawa, Ontario, Canada.
  • Mangili A; Tufts University School of Medicine, Boston, MA, USA.
  • Padula MA; Division of Neonatology, The Children's Hospital of Philadelphia and University of Pennsylvania, USA.
  • Pande SL; Ministry of Health Uganda, Soroti Regional Referral Hospital, Uganda.
  • Pool V; Sanofi Pasteur Inc., Swiftwater, PA, USA.
  • Pourmalek F; School of Population and Public Health, University of British Columbia, Vancouver, Canada.
  • Varricchio F; Independent Consultant, Vaccinologist, USA.
  • Kochhar S; Global Healthcare Consulting, New Delhi, India.
  • Cutland CL; Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, Johannesburg, South Africa; Department of Science and Technology, National Research Foundation, Vaccine Preventable Diseases, South Africa; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Af
Vaccine ; 34(49): 6027-6037, 2016 12 01.
Article em En | MEDLINE | ID: mdl-27449077
More than 40% of all deaths in children under 5 years of age occur during the neonatal period: the first month of life. Immunization of pregnant women has proven beneficial to both mother and infant by decreasing morbidity and mortality. With an increasing number of immunization trials being conducted in pregnant women, as well as roll-out of recommended vaccines to pregnant women, there is a need to clarify details of a neonatal death. This manuscript defines levels of certainty of a neonatal death, related to the viability of the neonate, who confirmed the death, and the timing of the death during the neonatal period and in relation to immunization of the mother.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Mortalidade Infantil / Coleta de Dados / Morte Perinatal Tipo de estudo: Guideline Limite: Child / Female / Humans / Infant / Newborn / Pregnancy Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Mortalidade Infantil / Coleta de Dados / Morte Perinatal Tipo de estudo: Guideline Limite: Child / Female / Humans / Infant / Newborn / Pregnancy Idioma: En Ano de publicação: 2016 Tipo de documento: Article